Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

Responsive image


HTR2A

HTR2A
Identifikatori
AliasiHTR2A
Vanjski ID-jeviOMIM: 182135 MGI: 109521 HomoloGene: 68073 GeneCards: HTR2A
Lokacija gena (čovjek)
Hromosom 13 (čovjek)
Hrom.Hromosom 13 (čovjek)[1]
Hromosom 13 (čovjek)
Genomska lokacija za HTR2A
Genomska lokacija za HTR2A
Bend13q14.2Početak46,831,546 bp[1]
Kraj46,897,076 bp[1]
Obrazac RNK ekspresije


Više referentnih podataka o ekspresiji
Ontologija gena
Molekularna funkcija 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding
G protein-coupled receptor activity
virus receptor activity
signal transducer activity
G-protein alpha-subunit binding
G protein-coupled serotonin receptor activity
serotonin binding
neurotransmitter receptor activity
GO:0001948, GO:0016582 vezivanje za proteine
GO:0032403 protein-containing complex binding
Ćelijska komponenta citoplazma
integral component of membrane
citosol
projekcija ćelije
membrana
cell body fiber
integral component of plasma membrane
dendritic shaft
Akson
soma
Kaveole
GO:0016023 citoplazmatska vezikula
ćelijska membrana
dendrit
glutamatergic synapse
integral component of postsynaptic membrane
integral component of presynaptic membrane
Biološki proces detection of mechanical stimulus involved in sensory perception of pain
release of sequestered calcium ion into cytosol
regulation of dopamine secretion
phospholipase C-activating serotonin receptor signaling pathway
urinary bladder smooth muscle contraction
positive regulation of MAP kinase activity
behavioral response to cocaine
positive regulation of cytosolic calcium ion concentration
positive regulation of kinase activity
positive regulation of phosphatidylinositol biosynthetic process
GO:0010260 starenje
cellular calcium ion homeostasis
Ćelijska smrt
Memorija
activation of phospholipase C activity
detection of temperature stimulus involved in sensory perception of pain
protein localization to cytoskeleton
Spavanje
positive regulation of vasoconstriction
positive regulation of cell population proliferation
negative regulation of potassium ion transport
positive regulation of ERK1 and ERK2 cascade
artery smooth muscle contraction
positive regulation of peptidyl-tyrosine phosphorylation
viral entry into host cell
phosphatidylinositol 3-kinase signaling
Nocicepcija
temperature homeostasis
GO:0022415 viral process
positive regulation of fat cell differentiation
positive regulation of glycolytic process
negative regulation of synaptic transmission, glutamatergic
GO:0072468 Transdukcija signala
chemical synaptic transmission
serotonin receptor signaling pathway
phospholipase C-activating G protein-coupled receptor signaling pathway
G protein-coupled receptor signaling pathway
GO:0035737 životinjsko ponašanje
regulation of synaptic vesicle exocytosis
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
Izvori:Amigo / QuickGO
Ortolozi
VrsteČovjekMiš
Entrez
Ensembl
UniProt
RefSeq (mRNK)

NM_001165947
NM_000621
NM_001378924

NM_172812

RefSeq (bjelančevina)

NP_000612
NP_001159419
NP_001365853

NP_766400

Lokacija (UCSC)Chr 13: 46.83 – 46.9 Mbn/a
PubMed pretraga[2][3]
Wikipodaci
Pogledaj/uredi – čovjekPogledaj/uredi – miš

Receptor 5-HT2A je podtip receptora5-HT2 porodice serotononskih G protein-spregnutih receptora (GPCR).[4] Recweptor 5-HT2A je receptor ćelijske površine.[5] 5-HT je skraćenica za 5-hidroksi-triptamin, koji je serotonin. Ovo je glavni podtip ekscitacijskog receptora među GPCR za serotonin, iako 5-HT2A također može imati inhibitorni učinak[6] na određenim područjima kao što su vizuelni i orbitofrontalni korteks.[7] Ovaj receptor je prvi put zapažen po svom značaju kao meta serotonergični psihodelični lijekovi kao što su LSD i psilocibinska gljiva. Kasnije se vratio na vidjelo jer je utvrđeno da je barem djelomično posredovao u djelovanju mnogih antipsihotičnih lijekova, posebno atipskih.

Smanjena regulacija postsinapsnihih receptora 5-HT2A je adaptivni proces izazvan hroničnom primjenom selektivnih inhibitora preuzimanja serotonina (SSRI) i atipskih antipsihotika. Samoubilački i na drugi način depresivni pacijenti imali su više receptora 5-HT2A od normalnih pacijenata. Ovi nalazi ukazuju na to da je postsinapsna prekomjerna gustoća 5-HT2A uključena u patogenezu depresije.[8]

Paradoksalna podregulacija receptora 5-HT2A može se primijetiti s nekoliko antagonista 5-HT 2A.[9] Prema tome, umjesto tolerancije, od antagoniste 5-HT2A očekivala bi se reverzna tolerancija. Međutim, na ovom mjestu postoji barem jedan antagonist za koji je pokazano da poboljšava receptore 5-HT2A.[10] Osim toga, nekoliko drugih antagonista možda neće uticati na broj receptora 5-HT2A.[11] Ipak, nadregulacija je prije izuzetak nego pravilo. Niti tolerancija niti odskok ne primjećuju se kod ljudi s obzirom na SWS koji promovira efekte antagonista 5-HT2A.[12]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000102468 - Ensembl, maj 2017
  2. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ Cook EH, Fletcher KE, Wainwright M, Marks N, Yan SY, Leventhal BL (august 1994). "Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor". Journal of Neurochemistry. 63 (2): 465–9. doi:10.1046/j.1471-4159.1994.63020465.x. PMID 8035173. S2CID 40207336.
  5. ^ Kling A (2013). 5-HT2A: a serotonin receptor with a possible role in joint diseases (PDF). Umeå: Umeå Universitet. ISBN 978-91-7459-549-9.
  6. ^ Martin P, Waters N, Schmidt CJ, Carlsson A, Carlsson ML (1998). "Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone". Journal of Neural Transmission. 105 (4–5): 365–96. doi:10.1007/s007020050064. PMID 9720968. S2CID 20944107.
  7. ^ De Almeida RM, Rosa MM, Santos DM, Saft DM, Benini Q, Miczek KA (maj 2006). "5-HT(1B) receptors, ventral orbitofrontal cortex, and aggressive behavior in mice". Psychopharmacology. 185 (4): 441–50. doi:10.1007/s00213-006-0333-3. PMID 16550387. S2CID 33274637.
  8. ^ Eison AS, Mullins UL (1996). "Regulation of central 5-HT2A receptors: a review of in vivo studies". Behavioural Brain Research. 73 (1–2): 177–81. doi:10.1016/0166-4328(96)00092-7. PMID 8788498. S2CID 4048975.
  9. ^ Yadav PN, Kroeze WK, Farrell MS, Roth BL (oktobar 2011). "Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo". The Journal of Pharmacology and Experimental Therapeutics. 339 (1): 99–105. doi:10.1124/jpet.111.183780. PMC 3186284. PMID 21737536.
  10. ^ Rinaldi-Carmona M, Congy C, Simiand J, Oury-Donat F, Soubrie P, Breliere JC, Le Fur G (januar 1993). "Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain". Molecular Pharmacology. 43 (1): 84–9. PMID 8423772.
  11. ^ Gray JA, Roth BL (novembar 2001). "Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists". Brain Research Bulletin. 56 (5): 441–51. doi:10.1016/s0361-9230(01)00623-2. PMID 11750789. S2CID 271925.
  12. ^ Vanover KE, Davis RE (28. 7. 2010). "Role of 5-HT2A receptor antagonists in the treatment of insomnia". Nature and Science of Sleep. 2: 139–50. doi:10.2147/nss.s6849. PMC 3630942. PMID 23616706.

Previous Page Next Page